Teams use different claims, and the supporting evidence, approved wording and current asset version are hard to trace.
Pharma & medtech / About
One industry.
A clear point of view.
Brand systems, approved product information and B2B communication for pharma and medtech teams. Build clarity around evidence, intended use and responsible review.
Our point of view
Evidence before expression.
Not one-size-fits-all.
Claim registers, review ownership and controlled templates. That is a different brief from life-science services, where the work begins with capability positioning, technical material and appropriate B2B handoffs.
We scope the work around the audience, your existing assets and the team that will handle the next step. The outcome is a practical programme you can inspect—not a list of disconnected activities.
What we actually fix
Every published claim connected to an approved source and version.
Posts, videos, pages and ads are deliverables. The engagement is about one thing: more of an approved, traceable publication.
A product-specific claim-to-source register, an approved messaging library, audience-appropriate content, version control, a reviewer workflow and a process to withdraw outdated material.
Managing scientific content with traceable evidence and a responsible publication process, with qualified reviewers.
- Approval turnaround
- Unsupported claims caught
- Outdated assets corrected
We compare like-for-like periods, so you see what actually changed—not just what went up.
In the age of AI
AI can make the assets.
We make them work.
Anyone can generate a logo, a post or a landing page in minutes. What moves a pharma & medtech business is judgement, accountability and knowing the rules of the industry.
AI tools can already give youWhat PharmaBrandX adds
Product brochures and social postsClaims traced to approved evidence and reviewed by medical/regulatory owners
A corporate websiteSeparate paths for healthcare professionals, partners and the public
Press-release draftsA publication approval log that stands up to audit
Unlimited drafts and optionsA decision on what to do first—and what can wait—with a named person accountable for it
The working principles
Considered work.
Clear responsibilities.
The business comes first.
Positioning, communication and trust work should connect to a real customer question and an agreed operational next step.
The detail matters.
Language, identity, page structure and response handling should feel like parts of the same considered experience.
Evidence has an owner.
Facts, permissions, approvals, accounts and outcomes are documented rather than implied.
How the team is organised
Roles, not invented
credentials.
- Strategy lead: agrees the business brief and priorities
- Design and content: develops agreed materials and templates
- Implementation: connects the selected pages, forms and handoffs
- Client approver: verifies facts, claims, access and permissions
- Client operations: owns service delivery and recorded business outcomes
Our commitments
Promises you can
hold us to.
Not results we cannot control—the way we work, written down.
A written scope before any payment
Deliverables, quantities, revisions, timeline and exclusions are agreed in writing first.
You own every account and file
Domains, ad accounts, profiles and final assets stay in your name, with role-based access for us.
No fake reviews, followers or rankings
We never buy or incentivise reviews, inflate numbers or promise positions we cannot control.
Claims checked before they go live
Every factual or professional claim is checked against your evidence and industry rules first.
A day-90 decision point
Review the evidence together, then continue, change or stop—no lock-in beyond the agreed scope.
A handover you can use
Final files, usage guide, access record and next priorities, even if you stop working with us.
Built for pharma & medtech
Know the rules.
Show the proof.
Industry expertise is the part a generic agency or an AI tool cannot fake. Every claim we help publish is checked against these first.
Rules we work within
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
- Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024
- Drugs and Cosmetics Rules on promoting prescription medicines to the public
- ASCI guidelines on health claims
Pointers for review, not legal advice. Specialist sign-off is arranged where your claims need it.
What a trustworthy pharma & medtech brand shows
- Approved, referenced product information
- Clear manufacturing and quality credentials
- Pharmacovigilance / adverse-event contact
- Separate HCP information
Use this to judge any provider—including us.
The next considered step
Evidence before expression.
Let’s start there.
Tell us about the business, the gap and the work you need. Start with a useful brief—not a bigger package.